0001567619-20-012533.txt : 20200624 0001567619-20-012533.hdr.sgml : 20200624 20200624165331 ACCESSION NUMBER: 0001567619-20-012533 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200623 FILED AS OF DATE: 20200624 DATE AS OF CHANGE: 20200624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Neil Thomas P. CENTRAL INDEX KEY: 0001640645 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39041 FILM NUMBER: 20986192 MAIL ADDRESS: STREET 1: SATSUMA PHARMACEUTICALS, INC. STREET 2: 400 OYSTER POINT BOULEVARD, SUITE 221 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Satsuma Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001692830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813039831 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 221 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 64080 BUSINESS PHONE: 415-505-0809 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 221 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 64080 4 1 doc1.xml FORM 4 X0306 4 2020-06-23 0 0001692830 Satsuma Pharmaceuticals, Inc. STSA 0001640645 O'Neil Thomas P. C/O SATSUMA PHARMACEUTICALS, INC. 400 OYSTER POINT BOULEVARD, SUITE 221 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Financial Officer Common Stock, $0.0001 par value 2020-06-23 4 M 0 2115 1.04 A 2115 D Common Stock, $0.0001 par value 2020-06-23 4 S 0 2115 35.2302 D 0 D Stock Option (Right to Buy) 1.04 2020-06-23 4 M 0 2115 0.00 D 2029-01-29 Common Stock 2115 74480 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. The transaction was executed in multiple trades in prices ranging from $35.00 to $35.54, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Twenty Five Percent (25%) of the shares subject to the option vest one year measured from January 14, 2019 (the "Vesting Commencement Date") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Thomas P. O'Neil 2020-06-24